General Hospital Psychiatry
Volume 31, Issue 6 , Pages 538-545 , November 2009

Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study

  • Seth Himelhoch, M.D., M.P.H.

      Affiliations

    • Department of Psychiatry, University of Maryland, Baltimore, MD 21201, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 706 3421; fax: +1 410 706 0022.
    • ,
  • Joshua S. Josephs, B.A.

      Affiliations

    • Department of Medicine, Johns Hopkins University, Baltimore, MD 21218, USA
    • ,
  • Geetanjali Chander, M.D., M.P.H.

      Affiliations

    • Department of Medicine, Johns Hopkins University, Baltimore, MD 21218, USA
    • ,
  • P. Todd Korthuis, M.D.

      Affiliations

    • Department of Medicine, Oregon Health and Science University, Portland, OR, USA
    • ,
  • Kelly A. Gebo, M.D., M.P.H.

      Affiliations

    • Department of Medicine, Johns Hopkins University, Baltimore, MD 21218, USA
    • ,
  • For the HIV Research Network

Received 21 November 2008 ,Accepted 20 May 2009.

References 

  1. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–728
  2. Vitiello B, Burnam MA, Bing EG, Beckman R, Shapiro MF. Use of psychotropic medications among HIV-infected patients in the United States. Am J Psychiatry. 2003;160(3):547–554
  3. Burnam MA, Bing EG, Morton SC, Sherbourne C, Fleishman JA, London AS, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58(8):729–736
  4. Fleishman JA, Gebo KA, Reilly ED, Conviser R, Christopher MW, Todd KP, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002. Med Care. 2005;43(9 Suppl):III40–III52
  5. Gebo KA, Fleishman JA, Reilly ED, Moore RD. High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States. Med Care. 2005;43(9 Suppl):III23–III30
  6. Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19(9):1134–1140
  7. Bozzette SA, Berry SH, Duan N, Frankel MR, Leibowitz AA, Lefkowitz D, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998;339(26):1897–1904
  8. Galvan FH, Bing EG, Fleishman JA, London AS, Caetano R, Burnam MA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63(2):179–186
  9. National Institute on Alcohol Abuse and Alcoholism . Helping people who drink too much: a clinician's guide. Rockville, MD: NIAAA; 2005;
  10. Hosmer DW, Lemeshow S. In: Model Development. Applied Survival Analysis. New York: John Wiley & Sons, Inc.; 1999;p. 158–195
  11. Miranda J, Cooper LA. Disparities in care for depression among primary care patients. J Gen Intern Med. 2004;19(2):120–126
  12. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA. 2002;287(2):203–209
  13. Stockdale SE, Lagomasino IT, Siddique J, McGuire T, Miranda J. Racial and ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995–2005. Med Care. 2008;46(7):668–677
  14. Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47(4):449–458
  15. Himelhoch S, Medoff DR. Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS. 2005;19(12):813–822
  16. Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30(4):401–409
  17. Turner BJ, Fleishman JA, Wenger N, London AS, Burnam MA, Shapiro MF, et al. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med. 2001;16(9):625–633
  18. Sambamoorthi U, Walkup J, Olfson M, Crystal S. Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. J Gen Intern Med. 2000;15(5):311–320
  19. Yun LWH, Maravi M, Koayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38(4):432–438
  20. Cook JA, Grey D, Burke-Miller J, Cohen MH, Anastos K, Gandhi M, et al. Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in US multi-site cohort of HIV-positive women. AIDS Care. 2006;18(2):93–100
  21. Ashman JJ, Conviser R, Pounds MB. Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care. 2002;(Suppl 1):S109–S118
  22. Lo W, MacGovern T, Bradford J. Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care. 2002;(Suppl 1):S45–S57
  23. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642–654
  24. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629–640

☆ Sponsorship: Supported by the National Institutes of Drug Abuse: Dr. Himelhoch (K23- DA019820) and Dr. Korthuis (K23-DA019809). Dr. Gebo is supported by the Agency for Healthcare Research and Quality (290-01-012) and Aging (R01 AG026250). Dr. Gebo also received support from the Johns Hopkins University Richard S. Ross Clinician Scientist Award.

☆☆ Disclaimer: The views expressed in this article are those of the authors. No official endorsement by DHHS, the National Institutes of Health or the Agency for Healthcare Research and Quality is intended or should be inferred.

★ Presentation: This article was accepted in poster form at the American Public Health Association Annual Meeting, San Diego, CA, November 2008.

PII: S0163-8343(09)00097-8

doi: 10.1016/j.genhosppsych.2009.05.009

General Hospital Psychiatry
Volume 31, Issue 6 , Pages 538-545 , November 2009

Article Tools